Associated Papers
Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya.
Ngayo MO et al.
Plos One, 2022
Efavirenz pharmacogenetics in a cohort of Italian patients.
Cusato J et al.
International Journal of Antimicrobial Agents, 2016
CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patients.
Olagunju A et al.
Therapeutic Drug Monitoring, 2014
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
Wyen C et al.
The Journal of Antimicrobial Chemotherapy, 2011
Select a paper to view details